59-64.
74. Murphy TP, Cutlip DE, Regensteiner JG, Mohler ER, Cohen DJ,
Reynolds MR, et al. Supervised exercise versus primary stenting for
claudication resulting from aortoiliac peripheral artery disease: sixmonth outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation 2012;125:
130-9.

Conte and Pomposelli et al 35S

75. Elhadd TA, Jung RT, Newton RW, Stonebridge PA, Belch JJ. Incidence of asymptomatic peripheral arterial occlusive disease in diabetic
patients attending a hospital clinic. Adv Exp Med Biol 1997;428:
45-8.
76. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS,
Heckbert SR, et al. Health outcomes associated with antihypertensive
therapies used as Ô¨Årst-line agents. A systematic review and metaanalysis. JAMA 1997;277:739-45.
77. Radack K, Deck C. Beta-adrenergic blocker therapy does not worsen
intermittent claudication in subjects with peripheral arterial disease. A
meta-analysis of randomized controlled trials. Arch Intern Med
1991;151:1769-76.
78. Gustafsson F, Torp-Pedersen C, Kober L, Hildebrandt P. Effect
of angiotensin converting enzyme inhibition after acute
myocardial infarction in patients with arterial hypertension.
TRACE Study Group, Trandolapril Cardiac Event. J Hypertens
1997;15:793-8.
79. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr,
Cuddy TE, et al. Effect of captopril on mortality and morbidity in
patients with left ventricular dysfunction after myocardial infarction.
Results of the survival and ventricular enlargement trial. The SAVE
Investigators. N Engl J Med 1992;327:669-77.
80. Yusuf S